Aurinia Pharmaceuticals Inc Stock Performance
as on October 17, 2025 at 10:43 pm IST
Day's Low
Day's High
$11.3$11.66
2.16%
Downside
0.95%
Upside
52 Week's Low
52 Week's High
$6.55$13.5443.29%
Downside
17.23%
Upside
Aurinia Pharmaceuticals Inc share price movements today
- Previous Close
- $11.55
- Open
- $11.50
- Volume
- 500.4K
- Day's Low - High
- $11.3 - $11.66
- 52 Week Low - High
- $6.55 - $13.54
Aurinia Pharmaceuticals Inc Historical Returns
- 1 Month Return
- -6.1 %
- 3 Month Return
- + 27.34 %
- 1 Year Return
- + 60.86 %
- 3 Year Return
- + 53.39 %
- 5 Year Return
- -25.44 %
Aurinia Pharmaceuticals Inc Stock Fundamentals & Key Indicators
Check Aurinia Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.5B
EPS (TTM)
0.6483
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
30.67%
PE Ratio (TTM)
26.67
Industry PE ratio
-0.32286624203821657
PEG Ratio
0EBITDA
82.6M
Revenue (TTM)
260.1M
Profit Margin
23.31%
Return On Equity TTM
17.33%
Aurinia Pharmaceuticals Inc Stock Valuation
Track how Aurinia Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Aurinia Pharmaceuticals Inc in the last 5 years
Lowest (-56.37x)
September 30, 2024
Industry (-0.32x)
October 17, 2025
Today (26.67x)
October 17, 2025
Highest (90.66x)
December 31, 2024
Today’s Price to Earnings Ratio: 26.67x
Aurinia Pharmaceuticals Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Aurinia Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.5B | -25.44% | 26.67 | 23.31% | |
| BUY | $61.6B | 230.86% | -505.15 | -12.96% | |
| NA | $35.8B | NA | NA | -3.89% | |
| BUY | $104.6B | 87.37% | 29.01 | 31.86% | |
| BUY | $61.1B | -5.1% | 14.53 | 31.37% |
Stock Returns calculator for Aurinia Pharmaceuticals Inc Stock including INR - Dollar returns
The Aurinia Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Aurinia Pharmaceuticals Inc investment value today
Current value as on today
₹1,65,777
Returns
₹65,777
(+65.78%)
Returns from Aurinia Pharmaceuticals Inc Stock
₹60,864 (+60.86%)
Dollar Returns*
₹4,914 (+4.91%)
Analyst Recommendation on Aurinia Pharmaceuticals Inc Stock
Based on 13 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Aurinia Pharmaceuticals Inc. Average target price of $11.71
Aurinia Pharmaceuticals Inc Share Price Target
Get share price movements and forecasts by analysts on Aurinia Pharmaceuticals Inc.
What analysts predicted
1.37%UPSIDE
Target Price
$11.71
Current Price
$11.55
Analyzed by
13 Analysts
Target
$11.71
Aurinia Pharmaceuticals Inc target price $11.71, a slight upside of 1.37% compared to current price of $11.55. According to 13 analysts rating.
Aurinia Pharmaceuticals Inc Stock’s Investor Sentiment and Interest
Search interest for Aurinia Pharmaceuticals Inc Stock has increased by 92% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:92% versus previous 30 day period
Aurinia Pharmaceuticals Inc Quarterly Profit & Loss
All numbers in Millions USD
Aurinia Pharmaceuticals Inc Annual Profit & Loss
All numbers in Millions USD
Aurinia Pharmaceuticals Inc Quarterly Cash Flow
All numbers in Millions USD
Aurinia Pharmaceuticals Inc Annual Cash Flow
All numbers in Millions USD
Aurinia Pharmaceuticals Inc News & Key Events
Today's Timeline - 15 October
Wed, 04:13 PM
-Aurinia Pharmaceuticals to present new LUPKYNIS data at ACR and ASN conferences, enhancing understanding of lupus nephritis treatment.
Insights on Aurinia Pharmaceuticals Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, AUPH stock has moved up by 27.3%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 59.86M → 70.00M (in $), with an average increase of 7.5% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.1% return, outperforming this stock by 1.2%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 146.6% return, outperforming this stock by 93.2%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 23.34M → 21.51M (in $), with an average decrease of 7.8% per quarter
About Aurinia Pharmaceuticals Inc
| Organisation | Aurinia Pharmaceuticals Inc |
| Headquarters | #140, 14315 ? 118 Avenue, Edmonton, AB, Canada, T5L 4S6 |
| Industry | Health Technology |
| CEO | Mr. Peter S. Greenleaf M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Aurinia Pharmaceuticals Inc
Name | Title |
|---|---|
Mr. Stephen P. Robertson | Executive VP, General Counsel, Corporate Secretary & Chief Compliance Officer |
Dr. Gregory F. Keenan M.D. | Chief Medical Officer |
Ms. Andrea Levin Christopher | Executive Director of Corporate Communications & Investor Relations |
Dr. Premchandran Ramiya Ph.D. | Senior Vice President of Manufacturing & Supply Chain |
Mr. Peter S. Greenleaf M.B.A. | President, CEO & Director |
Mr. Joseph M. Miller CPA | Chief Financial Officer |
Mr. Matthew Maxwell Donley M.B.A. | Chief Operations Officer |
FAQs
What is Aurinia Pharmaceuticals Inc share price today?
Aurinia Pharmaceuticals Inc share price today is $11.55 as on . Aurinia Pharmaceuticals Inc share today touched a day high of $11.66 and a low of $11.3.
What is the 52 week high and 52 week low for Aurinia Pharmaceuticals Inc share?
Aurinia Pharmaceuticals Inc share touched a 52 week high of $13.54 on and a 52 week low of $6.55 on . Aurinia Pharmaceuticals Inc stock price today i.e. is trending at $11.55,which is 14.70% down from its 52 week high and 76.34% up from its 52 week low.
What is Aurinia Pharmaceuticals Inc's market capitalisation today?
Aurinia Pharmaceuticals Inc market capitalisation is $0.00T as on .
How to invest in Aurinia Pharmaceuticals Inc Stock (AUPH) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Aurinia Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aurinia Pharmaceuticals Inc Shares that will get you 0.1299 shares as per Aurinia Pharmaceuticals Inc share price of $11.55 per share as on October 17, 2025 at 10:43 pm IST.
What is the minimum amount required to buy Aurinia Pharmaceuticals Inc Stock (AUPH) from India?
Indian investors can start investing in Aurinia Pharmaceuticals Inc (AUPH) shares with as little as ₹88.054 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.54 in Aurinia Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Aurinia Pharmaceuticals Inc share’s latest price of $11.55 as on October 17, 2025 at 10:43 pm IST, you will get 0.8658 shares of Aurinia Pharmaceuticals Inc. Learn more about
fractional shares .
What are the returns that Aurinia Pharmaceuticals Inc has given to Indian investors in the last 5 years?
Aurinia Pharmaceuticals Inc stock has given -25.44% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?